| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 10,074 | 16,216 | 15,078 | 15,710 | | Cost of Revenue | 2,823 | 3,374 | 3,611 | 4,044 | | | Gross Profit |
-
| 12,842 | 11,467 | 11,666 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,677 | 6,585 | 8,084 | 6,500 | | Non Recurring | (68) | (1,471) | 1,539 | 29,188 | | Others | 5,542 | 6,058 | 774 | 22,658 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 1,670 | 1,070 | (46,680) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (4,900) | 1,670 | 1,070 | (46,680) | | Interest Expense | 1,664 | 1,700 | 1,596 | 1,620 | | Income Before Tax | (6,564) | (30) | (526) | (48,300) | | Income Tax Expense | 12,571 | (133) | (427) | (6,126) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (19,135) | 103 | (99) | (42,174) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (19,135) | 103 | (99) | (42,174) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($19,135) | $103 | ($99) | ($42,174) |
|
0.31% Nasdaq 
0.05%
Income Statement
